Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

J Pediatric Infect Dis Soc. 2022 May 30;11(5):225-228. doi: 10.1093/jpids/piac003.

Abstract

The SARS-CoV-2 pandemic has caused an increase in antibiotic use in different settings. We describe the antibiotic prescribing prevalence, associated factors and trends, as well as concomitant bacterial infections in children hospitalized with COVID-19 or multisystemic inflammatory syndrome related to SARS-CoV-2 in Spain.

Keywords: COVID-19; SARS-CoV-2; antibiotic stewardship; bacterial infections; children.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19* / complications
  • COVID-19* / epidemiology
  • Child
  • Humans
  • Prevalence
  • SARS-CoV-2
  • Spain / epidemiology
  • Systemic Inflammatory Response Syndrome

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related